USD 0.0
(-10.0%)
Breakdown | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|
Revenue | 181.05 Thousand | 335.76 Thousand | - | - |
Cost of Revenue | 89.46 Thousand | 102.8 Thousand | - | - |
Gross Profit | 91.59 Thousand | 232.95 Thousand | - | - |
Operating Expenses | 2.49 Million | 921.06 Thousand | 41.09 Thousand | 12.61 Thousand |
Selling, General and Administrative Expenses | 2.49 Million | 921.06 Thousand | 41.09 Thousand | 12.61 Thousand |
Research and Development Expenses | 53.81 Thousand | 23.12 Thousand | - | - |
Other Expenses | - | - | - | - |
Cost and Expenses | 2.49 Million | 921.06 Thousand | 41.09 Thousand | 12.61 Thousand |
Operating Income | -2.31 Million | -585.29 Thousand | -41.09 Thousand | -12.61 Thousand |
Interest Expense | 874.9 Thousand | 151.84 Thousand | - | - |
Income Tax Expense | 869 Thousand | 135.86 Thousand | 41.09 Thousand | 12.61 Thousand |
Earnings before Tax | -3.33 Million | -478.06 Thousand | - | - |
Net Income | -3.33 Million | -462.08 Thousand | -41.09 Thousand | -12.61 Thousand |
Earnings Per Share Basic | -131.37 | -28.40 | -1.92 | -0.79 |
Earnings Per Share Diluted | -131.37 | -28.40 | -1.92 | -0.79 |
Weighted Average Shares Outstanding | 25.37 Thousand | 16.27 Thousand | 21.38 Thousand | 16 Thousand |
Weighted Average Shares Outstanding (Diluted) | 25.37 Thousand | 16.27 Thousand | 21.38 Thousand | 16 Thousand |
Gross Margin | 0.51 | 0.69 | - | - |
EBIT Margin | -12.78 | -1.74 | - | - |
Profit Margin | -18.41 | -1.38 | - | - |
EBITDA | -2.46 Million | -326 Thousand | -41.09 Thousand | -12.61 Thousand |
Earnings Before Tax Margin | -12.78 | -1.74 | - | - |
Breakdown | 2021 Q3 | 2020 Q3 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | 7958.00 |
Cost of Revenue | - | - | - | - | 893.00 | 41.08 Thousand |
Gross Profit | - | - | - | - | -893.00 | -33.12 Thousand |
Operating Expenses | 5632.00 | 34.00 | 174.72 Thousand | 140.42 Thousand | 148.11 Thousand | 504.19 Thousand |
Selling, General and Administrative Expenses | 5632.00 | 34.00 | 174.72 Thousand | 140.42 Thousand | 148.11 Thousand | 504.19 Thousand |
Research and Development Expenses | - | - | - | - | 893.00 | 5434.00 |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 5632.00 | 34.00 | 174.72 Thousand | 140.42 Thousand | 148.11 Thousand | 504.19 Thousand |
Operating Income | -5632.00 | -34.00 | -174.72 Thousand | -140.42 Thousand | -148.11 Thousand | -496.23 Thousand |
Interest Expense | - | - | 127.02 Thousand | 133.65 Thousand | 160.8 Thousand | 144.24 Thousand |
Income Tax Expense | -39.87 Thousand | - | 127.02 Thousand | 133.65 Thousand | 160.85 Thousand | 144.18 Thousand |
Earnings before Tax | -45.51 Thousand | -39.13 Thousand | -223.46 Million | -562.48 Thousand | -367.99 Thousand | -556.59 Thousand |
Net Income | -45.51 Thousand | -39.13 Thousand | -223.46 Million | -562.48 Thousand | -368.04 Thousand | -556.54 Thousand |
Earnings Per Share Basic | - | - | -161.67 | -0.90 | -7.71 | -21.93 |
Earnings Per Share Diluted | - | - | -161.67 | -0.90 | -7.71 | -21.93 |
Weighted Average Shares Outstanding | 4.55 Billion | - | 1.38 Million | 625.89 Thousand | 47.71 Thousand | 25.37 Thousand |
Weighted Average Shares Outstanding (Diluted) | 4.16 Billion | - | 1.38 Million | 625.89 Thousand | 47.71 Thousand | 25.37 Thousand |
Gross Margin | - | - | - | - | - | -4.16 |
EBIT Margin | - | - | - | - | - | -62.35 |
Profit Margin | - | - | - | - | - | -69.93 |
EBITDA | -39.87 Thousand | -23.00 | -174.64 Thousand | -140.34 Thousand | -148.04 Thousand | -496.16 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | -62.36 |
CSTAF
ISOLF
SBCF
BIOCQ
ASND
002199